SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Trulieve Files for $143 Million Tax Refund

    By

    This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A day long leadership summit focused on retail, investment & policy across New York and North America. Tickets on-sale now – www.cannabisnewyork.live

    Trulieve Cannabis Corp. has filed amended federal tax returns with refund claims of $143 million for several of its business entities for the years 2019, 2020, and 2021.

    Trulieve has stated that it believes it does not owe the money, however, there is no guarantee of receipt.

    The determination is supported by legal interpretations that challenge Trulieve’s tax liability under Section 280E of the Internal Revenue Code.

    The announcement followed the news that the company is relocating a medical cannabis dispensary in Melbourne, Florida.

    The company has stated that the new location at 1921 Alma Drive offers greater convenience to patients in southern Brevard County.

    Trulieve’s Chief Executive Officer Kim Rivers stated: “We are committed to finding the most convenient locations to best serve our Florida patients.

    “This relocation improves our ability to offer our broad assortment of products and first-class customer service to the Melbourne community.”

    In September, the company also announced the opening of a new dispensary in  Evans, Georgia, which will be Trulieve’s first dispensary in northeast Georgia.

    “Our focus in Georgia is not only providing medical cannabis for registered patients but also to help educate people about the potential benefits for their specific conditions,” stated Rivers.

    “We’re excited for the Evans location to serve as a venue for patient education and registration events as Georgia’s medical cannabis programme continues to grow.”

    Stephanie Price

    Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine ‘Game Theory’ focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on “Medical Cannabis Explained”.